Cargando…
Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2
Bioanalysis of complex biotherapeutics, such as antibody-drug conjugates (ADCs), is challenging and requires multiple assays to describe their pharmacokinetic (PK) profiles. To enable exposure-safety and exposure-efficacy analyses, as well as to understand the metabolism of ADC therapeutics, three b...
Autores principales: | Faria, Morse, Peay, Marlking, Lam, Brandon, Ma, Eric, Yuan, Moucun, Waldron, Michael, Mylott, William R., Liang, Meina, Rosenbaum, Anton I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640689/ https://www.ncbi.nlm.nih.gov/pubmed/31544817 http://dx.doi.org/10.3390/antib8010011 |
Ejemplares similares
-
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer
por: Pegram, Mark D., et al.
Publicado: (2021) -
Improving Antibody‐Tubulysin Conjugates through Linker Chemistry and Site‐Specific Conjugation
por: Hamilton, Joseph Z., et al.
Publicado: (2021) -
Sulfatase-cleavable linkers for antibody-drug conjugates
por: Bargh, Jonathan D., et al.
Publicado: (2020) -
Peroxide-cleavable linkers for antibody–drug conjugates
por: Ashman, Nicola, et al.
Publicado: (2023) -
Cleavable Cross-Linkers
Redefined by a Novel MS(3)-Trigger Algorithm
por: Kolbowski, Lars, et al.
Publicado: (2023)